Company Profile

Annidis Corporation develops and markets imaging technologies to eye care professionals. The Company has developed a multi-spectral imaging (MSI) system for retinal and choroidal assessment (the RHA). The RHA provides eye-care professionals with a screening tool for early detection and diagnosis of a range of pathologies. The RHA is an ocular pathology management system that integrates MSI with analytic software and management of ocular pathologies, such as glaucoma, age-related macular degeneration and diabetic retinopathy. Its RHA collects and combines multi-spectral information. The RHA is a non-invasive instrument that uses MSI to take pictures of the retinal layers of eye. The images are then processed using the RHA Report software to reveal various layers in the back of the eye. The Company is also engaged in developing RHA Platinum, which is under development with beta units in clinical testing that allows doctors to visualize choroidal and retinal vasculature non-invasively.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

18-02-26	Annidis Corporation Announces Executive Resignations	CI
17-11-23	Annidis Corporation Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2017	CI
17-08-25	Annidis Corporation Announces Unaudited Consolidated Financial Results for the Second Quarter and Six Months Ended June 30, 2017	CI
17-05-25	Annidis Corporation Announces Audited Consolidated Earnings Results for the First Quarter Ended March 31, 2017	CI
17-04-28	Annidis Corporation Announces Audited Consolidated Earnings Results for the Twelve Months Ended December 31, 2016	CI
17-02-24	Annidis Corporation Announces Executive Changes	CI
16-11-29	Annidis Corporation announced that it expects to receive CAD 2.18 million in funding	CI
16-09-21	Annidis Corporation Announces Private Placement of $500,000 Promissory Note	CI
16-09-07	Annidis Corporation Reports Unaudited Consolidated Earnings Results for the Second Quarter Ended June 30, 2016	CI
16-09-07	Annidis Corporation Announces the Resignation of Michael Mueller as Board of Director	CI
16-08-31	Annidis Corporation announced that it has received CAD 0.5 million in funding from Mistarunited Technology Co., Limited	CI
16-08-08	Annidis Corporation Announces Private Placement of $221,000 Promissory Note	CI
16-07-28	Annidis Corporation announced that it has received CAD 0.22 million in funding from Mistarunited Technology Co., Limited	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ANNIDIS CORPORATION	-.--%	-.--%	-	-	859K
THERMO FISHER SCIENTIFIC, INC.	+4.16%	+1.75%	+23.13%	+15.24%	227B
DANAHER CORPORATION	+5.97%	+2.77%	-0.33%	-15.87%	149B
INTUITIVE SURGICAL, INC.	+1.67%	-0.88%	-17.00%	+39.09%	141B
BOSTON SCIENTIFIC CORPORATION	+3.05%	+1.15%	-49.87%	+3.63%	75.37B
EDWARDS LIFESCIENCES CORPORATION	+1.43%	-0.83%	+16.91%	+20.50%	53.19B
SIEMENS HEALTHINEERS AG	+1.32%	+2.43%	-16.15%	-12.15%	51.88B
AGILENT TECHNOLOGIES, INC.	+4.70%	+4.84%	+29.39%	+30.32%	43.89B
WATERS CORPORATION	+3.64%	-0.07%	+39.67%	+54.01%	40.86B
GE HEALTHCARE TECHNOLOGIES INC.	+2.74%	+3.24%	+0.88%	+9.16%	33.7B
Average	+2.52%	+1.37%	+2.96%	+15.99%	90.55B
Weighted average by Cap.	+3.26%	+1.31%	+2.52%	+13.71%

Annidis Corporation Stock

Stocks

RHA.H

CA03589A1003

Advanced Medical Equipment & Technology

Latest news : Annidis Corporation

Other Advanced Medical Equipment & Technology

Company Profile